GDF-15 and FGF-23 are associated with mortality in type 2 diabetic patients with microalbuminuria

Keyphrases

• Hazard Ratio 100%
• Type 2 Diabetic Patients 100%
• Microalbuminuria 100%
• Fibroblast Growth Factor 23 (FGF23) 100%
• Growth Differentiation factor-15 (GDF-15) 100%
• All-cause Mortality 83%
• Estimated Glomerular Filtration Rate 66%
• Cardiovascular Disease 33%
• Adjusted Hazard Ratio 33%
• Urinary Albumin Excretion 33%
• Albumin Excretion Rate 33%
• CKD Progression 33%
• Incident Cardiovascular Disease 33%
• Cardiovascular Events 16%
• Systolic Blood Pressure 16%
• Hemoglobin A1c (HbA1c) 16%
• Creatinine 16%
• Coronary Artery Disease 16%
• Adjusted Model 16%
• Cox Model 16%
• Renal Outcome 16%
• LDL Cholesterol 16%
• Urinary Biomarkers 16%
• High Growth 16%
• Renal Pathophysiology 16%
• Rapid Kidney Function Decline 16%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 100%
• Diabetes Mellitus 100%
• Microalbuminuria 100%
• Fibroblast Growth Factor 23 100%
• Growth Differentiation Factor 15 100%
• Cardiovascular Disease 80%
• Biological Marker 40%
• Albumin 40%
• Maturity Onset Diabetes of the Young 40%
• Prospective Study 20%
• Low Density Lipoprotein Cholesterol 20%
• Pathophysiology 20%
• Creatinine 20%
• Hemoglobin A1c 20%
• Coronary Artery Disease 20%

Immunology and Microbiology

• All Cause Mortality 100%
• Growth Differentiation Factor 15 100%
• Fibroblast Growth Factor 23 100%
• Glomerulus Filtration 80%
• Cardiovascular System 80%
• Albumin 40%
• Kidney Function 20%
• Systolic Blood Pressure 20%
• Coronary Artery 20%